N-(4-(3-Bromo-5-methylphenyl)-5-(pyridin-4-yl)thiazol-2-yl)nicotinamide

ID: ALA5081520

PubChem CID: 166629521

Max Phase: Preclinical

Molecular Formula: C21H15BrN4OS

Molecular Weight: 451.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(Br)cc(-c2nc(NC(=O)c3cccnc3)sc2-c2ccncc2)c1

Standard InChI:  InChI=1S/C21H15BrN4OS/c1-13-9-16(11-17(22)10-13)18-19(14-4-7-23-8-5-14)28-21(25-18)26-20(27)15-3-2-6-24-12-15/h2-12H,1H3,(H,25,26,27)

Standard InChI Key:  BYCAMNPIFUUMNF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   44.8904   -4.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8893   -5.5452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.6015   -5.9583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   46.3153   -5.5447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.3124   -4.7179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5997   -4.3127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1785   -4.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1783   -3.4918    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.4668   -4.7219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.7590   -4.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6733   -3.4972    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   41.8698   -3.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4614   -4.0395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0125   -4.6465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.5382   -2.5795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0242   -1.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6882   -1.1639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8705   -1.0782    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.3899   -1.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7245   -2.4959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6466   -4.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1624   -3.4594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3463   -3.5447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0134   -4.2961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5027   -4.9631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3171   -4.8745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8661   -2.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1690   -5.7150    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  2  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 12 15  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 13 21  1  0
 23 27  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5081520

    ---

Associated Targets(Human)

ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora1 Adenosine A1 receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.35Molecular Weight (Monoisotopic): 450.0150AlogP: 5.59#Rotatable Bonds: 4
Polar Surface Area: 67.77Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.98CX Basic pKa: 4.02CX LogP: 4.93CX LogD: 4.93
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.71

References

1. Suresh RR, Gao ZG, Salmaso V, Chen E, Campbell RG, Poe RB, Liston TE, Jacobson KA..  (2022)  Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.,  13  (4.0): [PMID:35450351] [10.1021/acsmedchemlett.1c00685]

Source